Clinical Trials
3 trialsNCT07112612 2026-01-12
Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer
Anhui Medical University
Not yet recruiting
NCT05219734 2024-03-12
MARIA
Invitae Corporation
Active not recruiting
NCT02714790 2016-03-23
LAM-MMR
A.O.U. Città della Salute e della Scienza
Completed